GuruFocus.com is not operated by a broker or a dealer. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Managing Partner | RA Capital Management Peter is a founder and Managing Partner at RA Capital Management, active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. . But, as it often does, chance overrode plan, and they both fell in love with the property on the first visit. "Stay tuned for more covid and science explainers. Your email address will not be published. The Great American Drug Deal was released on January 20, 2020. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. He currently manages a fund that invests in healthcare and biotechnology companies. NEW ORLEANS Esperion Therapeutics revealed long-awaited data on its heart pills efficacy in cutting severe cardiovascular outcomes, three years after the drug was cleared for use to lower cholesterol levels. 2004-2023 GuruFocus.com, LLC. Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. Most recently he bought 4,000,000 units of WVE stock worth $80,000,000 on 23 June 2020. As of 23 June 2020 he still owns at least 9,011,651 units of Wave Life Sciences stock. Ilan Ganot, Director, Change), You are commenting using your Facebook account. This investment adviser does not provide advice to individual investors. Peter Kolchinsky owns over 4,000,000 units of Wave Life Sciences stock worth over $38,029,167 and over the last 9 years he sold WVE stock worth over $58,095,632. Everyone has been so generous with us, sharing advice and stories. Come and visit me at the Pacific Water Conference, booth 520! The real solution to affordability is hidden in plain sight amidst all the rhetoric about drug prices. Dr. Kolchinksy's hedge fund held 9.7 million Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) shares by the end of Q3 of 2021. See Peter Kolchinsky's compensation, career history, education, & memberships. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. New to Endpoints? Provides CEO, CFO, Director and Chief Executives trade reports, independent equity research, and stock screening. Please note this link is one-time use only and is valid for only 24 hours. The estimated Net Worth of Peter Kolchinsky is at least $105 Milion dollars as of 23 June 2020. Kolchinsky Peter Net Worth 2022 and insider trades. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Ben Ford was born and raised in Ames, Iowa. Peter Kolchinsky, PhD '01, is a founder, Portfolio Manager, and Managing Director at RA Capital Management, LLC, a multi-stage investment manager dedicated to evidence-based investing in healthcare and life sciences. Insider trading is most common in February, with the busiest year in 2023. When developed in combination with a medicinal asset, digital therapeutics enable significant market differentiation and significant benefits for stakeholdersfrom optimizing patient outcomes to supporting more efficient generation of compelling real-world data The estimated net worth of Peter Kolchinsky is at least $1.2 Billion dollars as of 2023-02-17. hope that what we do with the inn will come to reflect the spirit of this wonderful community. var _Hasync=_Hasync||[];_Hasync.push(['Histats.start','1,4553220,4,511,95,18,00000000']);_Hasync.push(['Histats.fasi','1']);_Hasync.push(['Histats.track_hits','']);(function(){var hs=document.createElement('script');hs.type='text/javascript';hs.async=true;hs.src=('//s10.histats.com/js15_as.js');(document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild(hs);})(); Peter Kolchinsky is a famous person who is known worldwide for his work. This is where youll find the low down on whats happening in and around the BHI. Health Care. We'll e-mail you a link to set a new password. The Entrepreneur's Guide to a Biotech Startup. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. He studied philosophy at Oregon State University and then earned a law degree from the University of Oklahoma. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. So they invited their close friends Keri and Ben up for what they expected to be a reality check. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. Carl Ashley Morris who sold 441 units worth After serving in the US Air Force JAG Corps, Ben worked at a private law firm and in Massachusetts state government. As the Independent Director of Wave Life Sciences, the total compensation of Peter Kolchinsky at Wave Life Sciences is $151,598. This free 100-page eBook is based on personal interviews with entrepreneurs, investors, attorneys, and other professionals . Keri is currently the Chair of the Religious Studies department at St. Pauls School for Girls in Baltimore, Maryland. Change), You are commenting using your Twitter account. Peter Kolchinsky overall profits are growing on a daily basis, and he is becoming more popular on the sidelines. Here we are at the BHI after a day of ripping out tile and installing shoe molding: And heres an article about us from The Vermont Standard that we thought you might enjoy. He studied philosophy at Oregon State University and then, a law degree from the University of Oklahoma. Peter Kolchinsky. Prevnar, a shot that prevents pneumococcal infections, is a Pfizer blockbuster. All Rights Reserved. the community will feel welcome. Dr. Peter Kolchinsky Ph.D. serves as Independent Director of the Company. Peter's wife, Anna, grew up in Germany, Austria, and France, and came to Bost on to attend Wellesley College. In a 2018 article, Eric Bender argued that cancer drugs aren't worth the price we pay for them and recommended legislative measures be taken to align prices with the values drugs provide. Please note GuruFocus will not track the insiders transaction performance if he/she does not have buying transactions. All Rights Reserved. She has a Masters in theological studies from Harvard Divinity School and began doctoral work in Buddhist studies at the University of California, Berkeley. Dr. Kolchinsky also leads RA Capitals engagement and publishing efforts, which aim to make a positive social impact and spark collaboration among healthcare stakeholders, including patients, physicians, researchers, policymakers, and industry. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. The campaign launched last year, targeting people in their 20s and 30s, Merz Aesthetics North America president Patrick Urban told Endpoints News at the time. He currently works with the State and Local Government Practice Group of the consulting firm Accenture. The most recent stock trade was executed by Chandra Vargeese on 16 February 2023, trading 10,249 units of WVE stock currently worth $41,303. Peter Kolchinsky usually trades in December, with the busiest year in 2022. The most active traders at the company are Anna maintains relationships with many people -- family . How do you see re-infections? He currently manages a fund that invests in healthcare and biotechnology companies. These two energetic couples are living their dream with energy, imagination, creativity and a whole lot of savvy business sense. By India Today Web Desk: With more than 22 lakh people infected, more than 1.5 lakh dead of the novel coronavirus, health experts all over the world are scrambling to understand just how did this one virus get so potent.. The two announced Monday morning that theyve put together their first pure-play venture fund at RA Capital Management, which has been known to bet on just about every angle in healthcare investing from rounds to follow-on investments at public companies. It was written by our very kind neighbor, Hasse K. Halley. 2001 - Present22 years. Stock quotes provided by InterActive Data. Anna and Peter originally hoped to find a vacation home that was big enough to share with friends and family and looked at the inn more out of curiosity than with any real intention to purchase it. Unlock this story instantly and join 161,900+ biopharma pros reading Endpoints daily and it's free. Franklin Resources Inc, After graduation he got $4 Million from Vertex Pharma co-founder Rich Aldrich and started picking biotech stocks at RA. . $3.3K . , Keri said, adding that she hopes the new business still allows her some time for her own writing. On average, Wave Life Sciences executives and independent directors trade stock every 39 days with the average trade being worth of $949,631. Peter Kolchinsky is a founder and Managing Partner at RA Capital Management and author of The Great American Drug Deal. Past performance is a poor indicator of future performance. The Great American Drug Deal examines the healthcare landscape through the lens of this contract, including the government's role in inventing drugs, direct-to-consumer advertising, the opioid crisis, the price-jacking of old drugs, and the impact on America of lower drug costs in other countries. The biopharmaceutical industry will be able to make a Covid-19 vaccineprobably a few of themusing various existing vaccine technologies. "And another thread that speaks to need for insurance reform. Current Endpoints readerscan visit their reader profileto add Endpoints Weekly. Peter Kolchinsky owns about 10,916,567 units of Solid Biosciences Inc common stock. $12.54M on September 23, 2020. One hopeful voice is biotech investor Peter Kolchinsky, the founder of RA Capital Management. Wallmine is a radically better financial terminal. Most recently he bought 6,337,135 units of KALA stock worth $49,999,995 on 13 March 2020 . Wave Life Sciences is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Peter Kolchinsky is 43, he's been the Independent Director of Wave Life Sciences since 2015. In addition, they want, Coming from diverse backgrounds and interests, the foursome. During. Welcome to the official Blue Horse Inn blog! Peter Kolchinsky is Chairman/CEO at Research Alliance Corp II. foundation had somehow failed patients by allowing Vertex to price its drugs so high that a 10 percent royalty could be worth so much. In . Nominations are now open for a special report that will highlight the contributions of LGBTQ+ biopharma leaders. Above is the net worth, insider trading, and ownership report for Kolchinsky Peter. Peter Kolchinsky Net Worth The estimated Net Worth of Peter Kolchinsky is at least Wave Life Sciences stock worth over $36,046,604 and over the last 8 years he sold WVE stock worth over $58,095,632. Your email address will not be published.